Molecular Biomarkers For Cancer Detection Market Segments and Key Trends 2016-2026

Shashiipawar37

Future Market Insights has announced the addition of the “Molecular Biomarkers For Cancer Detection Market Global Industry Analysis and Opportunity Assessment 2016 - 2026" report to their offering.

Global Molecular

Biomarkers For Cancer

Detection Market

Share, Global Trends,

Analysis, Research, Report,

Opportunities,

Segmentation and Forecast,

2016-2026

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com


Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and

Retail.

We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas

Customized

Research

Syndicated

Research

Investment

Research

Social Media

Research

Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com


Report Description

Molecular biomarkers are molecules which can be used as indicators for normal

biological processes, pathogenic processes and body’s response to pharmacological

processes. Molecular biomarkers for cancer detection provide information of an

individual’s likeliness to develop cancer, provide information on the type of cancer,

provide information on optimal drugs that can be used for the treatment of cancer,

whether the chances of cancer returning after going into remission persist, etc. Cancer

detection molecular biomarkers are usually made up of proteins, however, in recent

years the information related to cancer biomarkers has increased rapidly along with

developments in gene expression technology has led to the development of DNA-based

molecular biomarkers which can provide more specific information and early detection of

cancer. With the growing incidence cancer worldwide and rising economic burden caused

by cancer is expected to increase demand for early detection of cancer.

Molecular Biomarkers for Cancer Detection Market: Drivers and Restraints

Rising incidence of cancer globally is expected to boost the molecular biomarkers for

cancer detection market over the forecast period. As per the CDC (Centers for Disease

Control and Prevention) by 2025, 19.3 million cases of cancer cases are expected to be

diagnosed each year which in turn is supposed to increase demand for early detection of

cancer. Development of molecular biomarkers – blood-based strategies to detect and

monitor cancer is expected to boost demand for such biomarkers over the forecast

period. The paradigm shift towards personalized medicine for treatment of cancer is

expected to increase demand for cancer detection biomarkers as manufacturing


Report Description

personalized medicine depends on the pharmacological diagnosis of cancer.

Collaborations between research centers and manufacturers over the forecast period is

expected to boost the molecular biomarkers for cancer detection market. However, a

high cost of biomarkers and failure of products in R&D pipeline is expected to hamper the

market growth. As biomarkers are mostly derived from human tissue negative opinion

form patients is expected to slow revenue growth of the molecular biomarkers for cancer

detection. The low shelf life of biomarkers is also a critical factor which may reduce

adoption rate however with the development of biomarkers with increased shelf life by

the manufacturers over the forecast period the demand for molecular biomarkers for

cancer detection is expected to gain traction.

Request Free Report Sample@

http://www.futuremarketinsights.com/reports/sample/rep-gb-1788

Molecular Biomarkers for Cancer Detection Market: Segmentation

The global biomarkers for cancer detection market are segmented into three segments,

by cancer/tumor type, by end user and by region.

Segmentation by cancer/tumor type

• Breast cancer

• Lung cancer

• Prostate cancer


Report Description

• Colorectal cancer

• Cervical cancer

• Others

• Segmentation by end user

• Hospitals

• Specialty clinics

• Diagnostic centers

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1788

Molecular Biomarkers for Cancer Detection Market: Region – Wise Outlook

Regionally, North America is expected to be the dominant market. Rising incidence of

cancer and high adoption of biomarkers is expected to boost the demand for molecular

biomarkers for cancer detection. Western Europe is expected to follow next in adoption

of molecular biomarkers for cancer detection. Increasing research funding for

development of novel biomarkers and presence of key players in the North America and

Western Europe is expected to create high growth opportunities for biomarker

manufacturers in these regions. APEJ (Asia-Pacific excluding Japan) is expected to be next

followed by North America and Western Europe owing to increasing demand for cancer

diagnostics in India, Australia, and China. Japan is expected to witness the high adoption


Report Description

of molecular biomarkers owing to increasing R&D investment in cancer-related research

form the government and local clinical research organizations. Latin America and MEA

regions are expected to follow in line demand for molecular biomarkers for cancer

detection owing to changing global trend for cancer detection.

Molecular Biomarkers for Cancer Detection Market: Key Players

Some key players in the molecular biomarkers for cancer detection are Abbott

Laboratories, Agilent Technologies, Roche Diagnostics, Ltd., Qiagen N.V., Thermo Fisher

Scientific, Inc., Becton Dickenson & Company, Merck & Co, Inc.

Browse Full Report@

http://www.futuremarketinsights.com/reports/molecular-biomarkers-for-cancerdetection-market


Thank You!

To know more about us, please visit our website:

www.futuremarketinsights.com

For sales queries or new topics email us on:

sales@futuremarketinsights.com

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines